Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Hawkins

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
BMJ Open|September 23, 2024
The experiences of patients with oesophageal cancer receiving chemoradiotherapy treatment: a qualitative study embedded in the SCOPE2 trialDaniella Holland-Hart, Mirella Longo, Sarah Bridges, et al.
Acta Oncologica (Stockholm, Sweden)|September 4, 2008
Improving image-guided target localization through deformable registrationKristy K Brock, Maria Hawkins, Cynthia Eccles, et al.
International Journal of Radiation Oncology, Biology, Physics|January 7, 2021
Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal MetastasesMatthias Guckenberger, Frederick Mantel, Reinhart A Sweeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2008
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinomaRegina V Tse, Maria Hawkins, Gina Lockwood, et al.
BMC Medical Research Methodology|June 24, 2020
Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examplesErik van Werkhoven, Samantha Hinsley, Eleni Frangou, et al.
Radiation Oncology (London, England)|February 6, 2019
Driving developments in UK oesophageal radiotherapy through the SCOPE trialsS Gwynne, E Higgins, A Poon King, et al.
Cancer|March 3, 2018
Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 studyMatthias Guckenberger, Reinhart A Sweeney, Maria Hawkins, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2018
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National CohortChristopher M Jones, Richard Adams, Amy Downing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2019
Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancerMaxwell Robinson, Rebecca Muirhead, Clare Jacobs, et al.
Gut|April 16, 2024
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adultsAbid Suddle, Helen Reeves, Richard Hubner, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
BMJ Open|September 23, 2024
The experiences of patients with oesophageal cancer receiving chemoradiotherapy treatment: a qualitative study embedded in the SCOPE2 trialDaniella Holland-Hart, Mirella Longo, Sarah Bridges, et al.
Acta Oncologica (Stockholm, Sweden)|September 4, 2008
Improving image-guided target localization through deformable registrationKristy K Brock, Maria Hawkins, Cynthia Eccles, et al.
International Journal of Radiation Oncology, Biology, Physics|January 7, 2021
Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal MetastasesMatthias Guckenberger, Frederick Mantel, Reinhart A Sweeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2008
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinomaRegina V Tse, Maria Hawkins, Gina Lockwood, et al.
BMC Medical Research Methodology|June 24, 2020
Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examplesErik van Werkhoven, Samantha Hinsley, Eleni Frangou, et al.
Radiation Oncology (London, England)|February 6, 2019
Driving developments in UK oesophageal radiotherapy through the SCOPE trialsS Gwynne, E Higgins, A Poon King, et al.
Cancer|March 3, 2018
Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 studyMatthias Guckenberger, Reinhart A Sweeney, Maria Hawkins, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2018
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National CohortChristopher M Jones, Richard Adams, Amy Downing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2019
Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancerMaxwell Robinson, Rebecca Muirhead, Clare Jacobs, et al.
Gut|April 16, 2024
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adultsAbid Suddle, Helen Reeves, Richard Hubner, et al.
Pageof 4